ARCHIVES

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

This article is from The Cancer Letter archive.

Vol. 12 No. 07 | February 14, 1986

Download PDF Visit The Full Archive

Related Articles

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

October 29, 1999

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Lasker Awards Resume; ASCO Fall Conference Scheduled For October

September 21, 1990

Major League Baseball Begins Struggle to Eject Ever-Present Smokeless Tobacco Forom The Sport

April 12, 1991